Exhibit 99.1
ACCELRYS ANNOUNCES THIRD QUARTER RESULTS
Non-GAAP Revenue up 14% to $43.4 million

San Diego, October 31, 2012
- Accelrys, Inc. (NASDAQ: ACCL) today reported financial results for the fiscal quarter ended September 30, 2012, including a 14% year-over-year increase in Non-GAAP revenue.
Non-GAAP revenue for the quarter ended September 30, 2012 increased $5.4 million to $43.4 million from $38.0 million for the same quarter of the previous year, or an increase of 14%. Non-GAAP revenue for the nine months ended September 30, 2012, increased $12.6 million to $126.8 million from $114.1 million for the same period of the previous year, or an increase of 11%.
Non-GAAP net income was $6.3 million, or $0.11 per diluted share, for the quarter ended September 30, 2012 compared to non-GAAP net income of $5.4 million, or $0.10 per diluted share, for the same quarter of the previous year. Non-GAAP net income was $15.1 million, or $0.27 per diluted share, for the nine months ended September 30, 2012 compared to non-GAAP net income of $14.5 million, or $0.26 per diluted share, for the same period of the previous year.
GAAP revenue for the quarter ended September 30, 2012 increased $4.2 million to $40.5 million from $36.3 million for the same quarter of the previous year, or an increase of 12%. GAAP revenue for the nine months ended September 30, 2012 increased $13.8 million to $118.3 million from $104.6 million for the same period of the previous year, or an increase of 13%.
GAAP net income was $0.6 million, or $0.01 per diluted share, for the current quarter compared to GAAP net loss of $(2.2) million, or $(0.04) per diluted share, for the same quarter of the previous year. GAAP net loss was $(2.2) million, or $(0.04) per diluted share, for the nine months ended September 30, 2012 compared to GAAP net loss of $(12.4) million, or $(0.22) per diluted share, for the same period of the previous year.
“We delivered excellent results again this quarter, including double digit revenue growth for the second quarter in a row,” said Max Carnecchia, President & CEO of Accelrys.  “We also just concluded the acquisition of Aegis Analytical Corporation, thereby continuing to execute on our strategy of extending our portfolio from early research downstream into development, quality and manufacturing.  I am pleased to welcome the Aegis team to Accelrys and look forward to the strategic value we will bring to our customers through this combination.”

Recent Business Highlights:

Announced the acquisition of Aegis Analytical Corporation, expanding Accelrys' portfolio with industry-leading enterprise process intelligence capabilities.  Aegis software will be become part of the Accelrys Process Management and Compliance suite, providing organizations with unmatched insights into their product development, quality and manufacturing processes.

Announced the new integrated Accelrys Process Management and Compliance Suite, improving the way businesses manage the scientific innovation lifecycle by bringing products to market faster and at a lower cost, while meeting critical quality and regulatory compliance objectives.

Announced the latest release of Accelrys Electronic Laboratory Notebook (formerly Symyx Notebook by Accelrys), offering new capabilities that deliver a more complete biology solution for the fastest growing area of drug discovery and development.

Non-GAAP results for the three and nine months ended September 30, 2012 exclude the impact of business combination activities associated with the acquisitions of Contur Industry Holding AB and Contur Software AB (collectively, “Contur”) and VelQuest Corporation (“VelQuest”), both in 2011, and the merger with Symyx Technologies, Inc. (“Symyx”) in 2010, and other nonrecurring items.
Non-GAAP revenue, non-GAAP operating loss, and non-GAAP net income for the three and nine months ended September 30, 2012 include fair value adjustments to deferred revenue ($2.9 million and $8.4 million, respectively). Non-GAAP operating income for such three and nine-month periods also excludes stock-based compensation expense ($2.0 million and $5.6 million, respectively), business consolidation, transaction and restructuring costs ($0.7 million and $1.3 million, respectively) and purchased intangible asset amortization ($4.2 million and $12.6 million, respectively), offset by an adjustment to include acquisition-related cost of revenue related to VelQuest non-GAAP revenue recognized during such periods ($0.5 million and $1.2 million, respectively). In addition to the aforementioned items, non-GAAP net income for the same periods includes fair value adjustments to deferred royalty income ($0.2 million and $0.6 million, respectively) and excludes additional purchased intangible asset amortization ($0.4 million and $1.3 million, respectively) offset by removing the impact of the amortization of note receivable discount related to

1

The following information was filed by Accelrys, Inc. (ACCL) on Wednesday, October 31, 2012 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Accelrys, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accelrys, Inc..

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account